About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Baltimore | 454 Studies

Clinical Trials Prostate CancerBaltimore

Prostate Cancer Clinical Trials in Baltimore

Find 454 clinical trials for prostate cancer near Baltimore, Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Baltimore

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 454 trials

RecruitingTERPS Trial for de Novo Oligometastic Prostate CancerThis research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.NCT05223803·La Jolla, California and 9 others Active not recruitingAn International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male…NCT04720157·Scottsdale, Arizona and 166 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEvaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.The objective of this study is to evaluate a radiolabeled urea-based small molecule inhibitor of prostate-specific membrane antigen (PSMA), \[18F\]DCFPyL (DCFPyL) PET/CT (or…NCT03497377·Baltimore, Maryland

RecruitingPhase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate CancerThis is an open label, phase I, multi-center study aiming to assess the safety and tolerability in patients with metastatic castration resistant prostate cancer (mCRPC).NCT06801236·La Jolla, California and 12 others

UnknownDHA-Paclitaxel in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024414·Tucson, Arizona and 7 others

CompletedEnzalutamide/Leuprolide +/- Abiraterone/Pred in ProstateThis study is comparing the effectiveness of enzalutamide with or without abiraterone acetate for men with high-risk, localized prostate cancer.NCT02268175·Baltimore, Maryland and 3 others

CompletedEMPOWER Men to Reduce Weight and Inhibit Prostate Cancer ProgressionThis study will evaluate whether a lifestyle intervention focused on weight loss, EMPOWER, reduces prostate cancer progression at 12 months among men with biochemical recurrence…NCT04266431·Baltimore, Maryland

TerminatedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate CancerThis study consists of two phases: Dose Escalation (Phase 1b) and Dose Expansion (Phase 2) The Dose Escalation phase will characterize the safety, tolerability, and determine the…NCT02607228·San Francisco, California and 3 others

RecruitingSequential Testosterone and Enzalutamide Prevents Unfavorable ProgressionAsymptomatic men without pain due to prostate cancer progressing with metastatic CRPC after treatment with combination or sequential ADT + Abi will be treated on a randomized…NCT04363164·San Diego, California and 5 others

CompletedBrachytherapy in Treating Patients With Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy through seeds implanted into the prostate may kill more tumor cells.NCT00003312·Birmingham, Alabama and 257 others

CompletedHormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerRATIONALE: Androgens can stimulate the growth of prostate cancer cells.NCT00030654·Phoenix, Arizona and 77 others

TerminatedEPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCThis is a Phase 1/2 study of EPI-7386 orally administered in combination with enzalutamide in subjects with mCRPC.NCT05075577·Tucson, Arizona and 23 others

CompletedDarolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate CancerThe purpose of the study is to assess the efficacy and safety of BAY1841788 (darolutamide (ODM-201)) in combination with standard androgen deprivation therapy (ADT) and docetaxel…NCT02799602·Chandler, Arizona and 321 others

CompletedCu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate CancerThis is a prospective, open-label Phase 2 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent metastatic prostate cancer after radical…NCT05653856·New Haven, Connecticut and 8 others

CompletedCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003400·Baltimore, Maryland

RecruitingAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostate cancer (OMPC)…NCT05939414·Fayetteville, Arkansas and 143 others

CompletedAnalyses of Human Samples Collected in Clinical TrialsCancer patients in clinical trials donate various human samples (e.g., serum, plasma, blood, urine, feces, bile, saliva) for research purposes.NCT00339664·Washington D.C., District of Columbia and 16 others

SuspendedClariCore System Used in Transperineal Prostate BiopsyThe overall objective of this study is to acquire ultrasound images, spectral data and prostate tissue biopsy cores using the ClariCore System via a transperineal approach.NCT03734575·Baltimore, Maryland and 1 other

TerminatedStudy of KOS-862 (Epothilone D) in Metastatic Prostate CancerThe purpose of this trial is to study KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.NCT00104130·Vallejo, California and 8 others

CompletedAn Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based ChemotherapyThe purpose of this study is to evaluate the efficacy and safety of abiraterone acetate in participants with advanced prostate cancer (a disease in which cells in the prostate…NCT00485303·Los Angeles, California and 13 others

PreviousPage 2 of 23Next

Other Conditions in Baltimore

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma